Since its formation, Q30 Innovations has been focused on transforming the invention of two doctors into a safe, effective, and groundbreaking medical device to reduce the risk and severity of traumatic brain injury through partial jugular vein compression. Q30’s effort has included engaging leading engineers and fabricators to design and produce the Q-Collar, and working with world-renowned experts and independent researchers to perform more than 25 pre-clinical and clinical studies, 18 of which have resulted in published articles. On February 26, 2021, following a thorough evaluation of the research by the FDA, the Q-Collar became the first and only FDA-cleared device to reduce traumatic brain injury.

Today, the Q-Collar is available in the United States and Canada for use by athletes and military personnel who the Q-Collar help protect.

See How It Works